Searched for: person:kistei01
Predictors of marital disruption in multiple sclerosis [Meeting Abstract]
Mihai, C; Teter, B; Weinstock-Guttman, B; Christodoulou, C; Coyle, P; Drake, A; Frontera, A; Gauthier, S; Goodman, A; Gottesman, M; Granger, C; Herbert, J; Holub, R; Jubelt, B; Khan, M; Kister, I; Krupp, L; Lava, N; Lenihan, M; Lublin, F; Miller, A; Nealon, N; Schwid, S; Smiroldo, J; Snyder, D; Tullman, M; Zivadinov, R; Munschauer, F
ISI:000257197202030
ISSN: 0028-3878
CID: 112000
US severity scores in African Americans are dramatically worse than mon-African Americans: Analysis of the New York state MS consortium (NYSMSC) dataset [Meeting Abstract]
Kister, I; Bacon, J; De Guzman, RA; Teter, B; Christodoulou, C; Coyle, P; Frontera, A; Gauthier, S; Goodman, A; Gottesman, M; Granger, C; Holub, R; Jubelt, B; Khan, M; Krupp, L; Lava, N; Lenihan, M; Lublin, F; Mihai, C; Miller, A; Munschauer, F; Nealon, N; Schwid, S; Smiroldo, J; Snyder, D; Tullman, M; Weinstock-Guttman, B; Zivadinov, R; Herbert, J
ISI:000257197202014
ISSN: 0028-3878
CID: 111999
Natalizumab reduces multiple sclerosis severity: Analysis of patients from the AFFIRM and SENTINEL studies using the multiple sclerosis severity scale [Meeting Abstract]
Herbert, J; Kappos, L; Calabresi, P; Confavreux, C; Galetta, S; Giovannoni, G; Havrdova, E; Hutchinson, M; Lublin, F; Miller, D; O'Connor, PW; Phillips, J; Polman, C; Radue, EW; Rudick, R; Stuart, W; Wajgt, A; Weinstock-Guttman, B; Wynn, D; Bacon, J; Kister, I; Pace, A; Panzara, M
ISI:000257197201204
ISSN: 0028-3878
CID: 111998
Three cases of herpes reactivation in MS patients on Natalizumah monotherapy [Meeting Abstract]
Kister, I; Herbert, J
ISI:000251423400516
ISSN: 1352-4585
CID: 112002
Impact of headaches on the course of multiple sclerosis: preliminary results of a cross-sectional survey [Meeting Abstract]
Kister, I; Soliman, A; Fuman, L; Fromm, T; Bacon, J; Herbert, J; Lipton, R
ISI:000251423400375
ISSN: 1352-4585
CID: 112001
Impact of natalizumab on multiple sclerosis severity: analysis of patients and subgroups from the AFFIRM study using the Multiple Sclerosis Severity Scale [Meeting Abstract]
Herbert, J; Kappos, L; Giovannoni, G; Havrdova, E; Hutchinson, M; Lublin, F; Miller, D; O'Connor, P; Phillips, JT; Polman, CH; Wajgt, A; Bacon, J; Kister, I; Pace, A; Panzara, M
ISI:000251423400521
ISSN: 1352-4585
CID: 75898
Occurrence of CNS demyelinating disease in patients with myasthenia gravis [Letter]
Kister, I; Herbert, J; Swerdlow, M L; Bergamaschi, R; Piccolo, G; Oger, J
PMID: 17441230
ISSN: 1526-632X
CID: 91664
Neoplasm or demyelinating lesion?
Inglese M; Kister I; Gutstein H; Herbert J
ORIGINAL:0006766
ISSN: 1931-4159
CID: 112005
Localised scleroderma with enhancing brain lesions mimicking multiple sclerosis: a case report and literature review [Meeting Abstract]
Kister, I; Herbert, J
ISI:000251423400701
ISSN: 1352-4585
CID: 112003
Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy [Case Report]
Kister, Ilya; Gulati, Sandeep; Boz, Cavit; Bergamaschi, Roberto; Piccolo, Giovanni; Oger, Joel; Swerdlow, Michael L
BACKGROUND: Myasthenia gravis (MG) and neuromyelitis optica (NMO, also known as Devic disease) are rare autoimmune disorders, with upper-limit prevalence estimates in the general population of 15 per 100,000 and 5 per 100,000, respectively. To our knowledge, an association between these diseases has not been previously reported. OBJECTIVES: To describe 4 patients with MG who developed NMO after thymectomy and to analyze possible causes of apparent increased prevalence of NMO among patients with MG. DESIGN: Case series. PATIENTS: Four patients with MG who underwent thymectomy. INTERVENTIONS: None. RESULTS: The prevalence of MG within the published cohort of patients with NMO is more than 150 times higher than that in the general population. CONCLUSION: Dysregulation of B-cell autoimmunity in myasthenia, possibly exacerbated by loss of control over autoreactive cells as a result of thymectomy, may predispose patients to the development of NMO
PMID: 16769866
ISSN: 0003-9942
CID: 91641